Skip to main content
SpringerLink
Log in

Circulating levels of cell adhesion molecules in hypertension

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Hypertension causes complications such as coronary atherosclerosis and thrombosis wherein inflammatory factors play significant role. In the present study inflammatory molecules such as cell adhesion molecules (CAMs); endothelial (E)-selectin, platelet (P)-selectin, intercellular CAM-1 (ICAM-1), vascular CAM-1 (VCAM-1) and platelet endothelial CAM-1 (PECAM-1) were analysed in subjects newly diagnosed with hypertension with no secondary cause against normotensive healthy individuals. In each group 57 subjects were recruited and soluble (s) levels of CAMs were analysed by ELISA. As compared to controls median of sE-selectin (49.2%, P=0.001), sP-selectin (54.3%, P=0.001), and sICAM-1 (18.9%, P=0.012) were significantly elevated in hypertensive subjects. Significant negative correlation was observed of sP-selectin (spearman rank correlation coefficient (rs) =−0.345, p=0.027) and sPECAM-1 (rs =−0.446, p=0.003) with age in hypertension group. Hypertension may increase expression of certain CAMs while younger hypertensives in addition are also at increased risk of atherothrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 1998; 66: 65–72.

    Article  CAS  PubMed  Google Scholar 

  2. The National High Blood Pressure Education Program Working Group. Report on hypertension in diabetes. Hypertens 1994; 23: 145–158.

    Google Scholar 

  3. Ghaffar A, Reddy KS, Singhi M. Burden of noncommunicable diseases in South Asia. BMJ 2004; 328: 807–810.

    Article  PubMed  Google Scholar 

  4. Chobanian AV, Alexander RW. Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. Arch Intern Med 1996; 156: 1952–1956.

    Article  CAS  PubMed  Google Scholar 

  5. Alexander RW. Hypertension and the Pathogenesis of Atherosclerosis Oxidative Stress and the Mediation of Arterial Inflammatory Response: A New Perspective. Hypertension 1995; 25: 155–161.

    CAS  PubMed  Google Scholar 

  6. Ross R, Glomset J, Harker L: Response to injury and atherogenesis. Am J Pathol 1997; 86: 675–684.

    Google Scholar 

  7. Mulvihill N. T, Foley JB, Crean P, Walsh M. Prediction of cardiovascular risk using soluble cell adhesion molecules. Euro Heart J 2002; 23: 1569–1574.

    Article  CAS  Google Scholar 

  8. Muller WA, Weigl SA, Deng X, Philips. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449–460.

    Article  CAS  PubMed  Google Scholar 

  9. Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK, et al. State-of-the-art. Lecture: hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertens 1999; 33: 212–218.

    CAS  Google Scholar 

  10. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588–593.

    CAS  PubMed  Google Scholar 

  11. Cottone S, Mule G, Nardi E, Vadala A, Lorito MC, Guarneri M, et al. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension. J Hypertens 2007; 25: 423–428.

    Article  CAS  PubMed  Google Scholar 

  12. Griendling KK, Alexander RW. Cellular biology of blood vessels. In: The Heart Hurst’s 8th edn. Ed. Schlant RC, Alexander RW, McGraw-Hill Publication Co., New York, NY; 1994:pp31–45.

    Google Scholar 

  13. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709–720.

    CAS  PubMed  Google Scholar 

  14. Davies PF, Barbee KA, Volin MV, Robotewskyj A, Chen J, Joseph L, et al. Spatial relationships linearly signalling events of flow-mediated endothelial mechanotransduction. Ann Rev Physiol 1997; 59: 527–549.

    Article  CAS  Google Scholar 

  15. Buemi M, Allegra A, Aloisi C, Corica F, Alonci A, Ruello A, et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertens 1997; 30: 845–847.

    CAS  Google Scholar 

  16. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1995; 13: 1674–1678.

    PubMed  Google Scholar 

  17. Cottone S, Mule G, Amato F, Riccobene R, Vadala A, Lorito MC, et al. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J Nephrol 2002; 15: 643–648.

    CAS  PubMed  Google Scholar 

  18. Palomo I, Marín P, Alarcon M, Gubelin G, Vinambre X, Mora E, et al. Patients with essential hypertension present higher levels of sE-selectin and sVCAM-1 than normotensive volunteers. Clin Exp Hypertens 2003; 8: 517–523.

    Article  Google Scholar 

  19. DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 1997; 10: 1335–1341.

    CAS  PubMed  Google Scholar 

  20. Ferri C, Desideri G, Baldoncini R, Bellini C, Angelis C. Massocchi C, et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 1998; 47: 660–667.

    Article  CAS  PubMed  Google Scholar 

  21. Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens 1994; 12: 925–928.

    Article  Google Scholar 

  22. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491–495.

    CAS  PubMed  Google Scholar 

  23. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in highrisk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Int J Cardiol 2004:94: 293–300.

    Article  Google Scholar 

  24. Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med 2007; 261: 384–391.

    Article  CAS  PubMed  Google Scholar 

  25. Madej A, Okopien B, Kowalski J, Haberka M, Herman ZS. Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Int J Cardiol 2005; 98: 39–44.

    Article  Google Scholar 

  26. Hong S, Nelesen RA, Krohn PL, Mills PJ, Dimsdale JE. The association of social status and blood pressure with markers of vascular inflammation. Pharmacol Rep 2005; 57: 878–881.

    Google Scholar 

  27. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857–861.

    Article  CAS  PubMed  Google Scholar 

  28. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429–433.

    Article  CAS  PubMed  Google Scholar 

  29. Yusuf S, Reddy KS, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanisation. Circulation 2001; 104: 2746–2753.

    Article  CAS  PubMed  Google Scholar 

  30. Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC. Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population. J Hum Hypertens 2003; 17, 535–540.

    Article  CAS  PubMed  Google Scholar 

  31. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults: Executive summary of the third report of the National College of Education Program (ATPIII) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults: (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  32. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Sanucci A, et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertens 1999; 34: 568–573.

    CAS  Google Scholar 

  33. Miller MA, Kerry SM, Cook DG, Cappuccio FP. Cellular adhesion molecules and blood pressure: interaction with sex in a multi-ethnic population. J Hypertens 2004; 22: 705–711.

    Article  CAS  PubMed  Google Scholar 

  34. Lamon-fava S, Posfai B, Schaeger EJ. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules on postmenopausal women. Am J Cardiol 2003; 91: 252–254.

    Article  CAS  PubMed  Google Scholar 

  35. Kvasnicka T, Kvasnicka J, Ceska R, Grauova B, Vrablik M. Increasing plasma levels of soluble cell adhesion molecules (sE-Selectin, sP-Selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek 2001; 102: 473–477.

    CAS  PubMed  Google Scholar 

  36. Zeisler H, Livington JC, Schatten C, Tempfer C, Knofler M, Husslin P. Serum levels of adhesion molecules in women with pregnancy-induced hypertension. Wein Klin Wochenschr 2001; 113: 588–592.

    CAS  Google Scholar 

  37. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of pre-eclampsia. Am J Obstet Gynecol 1997; 177: 443–449.

    Article  CAS  PubMed  Google Scholar 

  38. Krauss T, Osmers R, Beran J, Diedrich F, Fleckenstein G, Kuhn W. Soluble adhesion molecules in patients with preeclampsia. Zentralbl Gynakol 1998; 120: 279–283.

    CAS  PubMed  Google Scholar 

  39. Li-Saw-Hee FL, Beevers DG, Lip GY. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomized double-blind parallel group trial. Int J Cardiol 2001; 78: 241–246.

    Article  CAS  PubMed  Google Scholar 

  40. Hlubocka Z, Umnerova V, Heller S, Peleska J, Jindra A, Jachymova M, et al. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von willebrand factor markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of ACE inhibitors. J Hum Hypertens 2002; 16: 557–562.

    Article  CAS  PubMed  Google Scholar 

  41. Conen D, Everett BM, Glynn RJ, Ridker PM. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart 2008; 94: e13.

    Article  CAS  PubMed  Google Scholar 

  42. Liu L, Zhao SP, Zhou HN, Li QZ, Li JX. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. J Cardiovasc Pharmacol 2007; 50: 50–55.

    Article  CAS  PubMed  Google Scholar 

  43. Ridker PM, Danielson E, Rifai N, Glynn RJ; Val-MARC Investigators. Valsartan, blood pressure reduction, and Creactive protein: primary report of the Val-MARC trial. Hypertens 2006; 48: 73–79.

    Article  CAS  Google Scholar 

  44. Celik T, Yuksel UC, Iyisoy A, Kursaklioglu H, Ozcan O, Kilic S, et al. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol. Int J Cardiol 2007; 116: 206–211.

    Article  PubMed  Google Scholar 

  45. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002; 16: 539–547.

    Article  CAS  PubMed  Google Scholar 

  46. Sanada H, Midorikawa S, Yatabe J, Yatabe MS, Katoh T, Baba T, et al. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker. Hypertens Res. 2005; 28: 871–878.

    Article  CAS  PubMed  Google Scholar 

  47. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus. Thromb Res 2005; 115: 277–285.

    Article  CAS  PubMed  Google Scholar 

  48. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001; 104: 145–150.

    CAS  PubMed  Google Scholar 

  49. Chandalia M, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88: 3773–3776.

    Article  CAS  PubMed  Google Scholar 

  50. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003; 168: 305–313.

    Article  CAS  PubMed  Google Scholar 

  51. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006; 55: 1232–1238.

    Article  CAS  PubMed  Google Scholar 

  52. Lip GYH. Hypertension and the prothrombotic state. J Hum Hypertens 2000; 14: 687–690.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sir H. N. Medical Research Society, Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    Kavita K. Shalia, Rajashree A. Mokal, Shilpa M. Mithbawkar & Priti K. Thakur

  2. Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    Manoj R. Mashru & Jagdish B. Vasvani

Authors
  1. Kavita K. Shalia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manoj R. Mashru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jagdish B. Vasvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rajashree A. Mokal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shilpa M. Mithbawkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Priti K. Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kavita K. Shalia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shalia, K.K., Mashru, M.R., Vasvani, J.B. et al. Circulating levels of cell adhesion molecules in hypertension. Indian J Clin Biochem 24, 388–397 (2009). https://doi.org/10.1007/s12291-009-0070-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-009-0070-6

Key Words

Search

Navigation